Workshop 7D: From risk groups to risk environments: reframing hepatitis C for effective elimination
Tracks
Track 4
| Friday, October 9, 2026 |
| 2:00 PM - 3:30 PM |
| Leo + Virgo |
Details
What if we stopped asking who is at risk and started asking where risk is produced? This interactive workshop introduces a practical visual mapping tool designed to help advocates and policymakers have more productive conversations about the systems and environments that shape hepatitis C transmission and access to prevention and care.
Speaker
Ms Jennifer Van Gennip
Executive Director
Action Hepatitis Canada
From risk groups to risk environments: reframing hepatitis C for effective elimination
Biography
Jennifer van Gennip has led Action Hepatitis Canada (AHC) for 12 years, advancing national accountability for Canada’s commitment to eliminate viral hepatitis by 2030. A recognized leader in hepatitis C elimination, she specializes in structural policy reform, cross-sector collaboration, and equity-focused strategies spanning health, housing, and community systems.
Mr Matthew Bonn
Drug Culture Advisor
ChangeMark Research & Evaluation
Welcome
2:00 PM - 2:05 PMBiography
Ms Jennifer Van Gennip
Executive Director
Action Hepatitis Canada
Welcome
2:00 PM - 2:05 PMBiography
Mr Matthew Bonn
Drug Culture Advisor
ChangeMark Research & Evaluation
Presentation on the report
2:05 PM - 2:20 PMBiography
Ms Jennifer Van Gennip
Executive Director
Action Hepatitis Canada
Presentation on the report
2:05 PM - 2:20 PMBiography
Mr Matthew Bonn
Drug Culture Advisor
ChangeMark Research & Evaluation
Introduction and demonstration of the visual
2:20 PM - 2:30 PMBiography
Ms Jennifer Van Gennip
Executive Director
Action Hepatitis Canada
Introduction and demonstration of the visual
2:20 PM - 2:30 PMBiography
Mr Matthew Bonn
Drug Culture Advisor
ChangeMark Research & Evaluation
Individual reflection and instructions
2:30 PM - 2:35 PMBiography
Ms Jennifer Van Gennip
Executive Director
Action Hepatitis Canada
Individual reflection and instructions
2:30 PM - 2:35 PMBiography
Mr Matthew Bonn
Drug Culture Advisor
ChangeMark Research & Evaluation
Small group mapping conversations
2:35 PM - 3:05 PMBiography
Ms Jennifer Van Gennip
Executive Director
Action Hepatitis Canada
Small group mapping conversations
2:35 PM - 3:05 PMBiography
INHSU 2026
Discussion and closing
3:05 PM - 3:30 PMBiography
